CLINICAL_TRIALS
research
· 2013-10-11
Clinical Trial Update: ADALISKIAS: Adalimumab for Acute Disc Prolapse [Phase 3]
Summary
A Phase 3 trial update on adalimumab for acute lumbar disc herniation (disc prolapse), with the current status not disclosed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Kuopio University Hospital | Conditions: Disc Prolapse, Pain | Phase 3 | Status: UNKNOWN